Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001)

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
Jesús OteoSpanish EARSS Group

Abstract

This study examined the antimicrobial resistance of 1,278 invasive Streptococcus pneumoniae isolates from 41 Spanish laboratories participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2000 and 2001. Twenty-nine laboratories participated during both years and provided 950 of the isolates. Each laboratory used its own susceptibility testing methods. External quality assessment was performed annually by each participating laboratory. Significant increases in penicillin and erythromycin resistance were observed between 2000 and 2001. This increase was particularly noticeable in isolates from the laboratories participating during both years and in isolates from children and elderly patients.

References

Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B R LevinF M Stewart
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J AustinR M Anderson
Mar 7, 2000·The Journal of Antimicrobial Chemotherapy·A R BremónR L Rodríguez
Sep 21, 2000·The Journal of Antimicrobial Chemotherapy·G C SchitoA Marchese
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·Ralf René ReinertRudolf Lütticken
Apr 3, 2002·Emerging Infectious Diseases·Stef L A M BronzwaerUNKNOWN European Antimicrobial Resistance Surveillance System
May 11, 2002·The Journal of Antimicrobial Chemotherapy·Marja PihlajamäkiUNKNOWN Finnish Study Group for Antimicrobial Resistance
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·J OteoUNKNOWN Spanish members of the European Antimicrobial Resistance Surveillance System

❮ Previous
Next ❯

Citations

May 4, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C García-ReyF Baquero
Apr 29, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I ParaskakisUNKNOWN National Surveillance Network for Pneumococcal Resistance
Jan 22, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M A BorgUNKNOWN ARMed Project members and collaborators
May 23, 2009·PloS One·Hany S GirgisSaeed Tavazoie
Jul 17, 2004·Metabolic Engineering·Michael D LynchGregory Stephanopoulos
Feb 8, 2006·Trends in Biotechnology·David M Klaus, Heather N Howard
Mar 20, 2008·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·P M Olaechea AstigarragaUNKNOWN INfectious Diseases Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Lance R Peterson
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
G W Waterer
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S HarbarthD Pittet
© 2021 Meta ULC. All rights reserved